146 related articles for article (PubMed ID: 16102579)
1. Chromosomal aberrations in cell lines derived from thyroid tumors spontaneously developed in TRbetaPV/PV mice.
Zimonjic DB; Kato Y; Ying H; Popescu NC; Cheng SY
Cancer Genet Cytogenet; 2005 Sep; 161(2):104-9. PubMed ID: 16102579
[TBL] [Abstract][Full Text] [Related]
2. A tumor suppressor role for thyroid hormone beta receptor in a mouse model of thyroid carcinogenesis.
Kato Y; Ying H; Willingham MC; Cheng SY
Endocrinology; 2004 Oct; 145(10):4430-8. PubMed ID: 15231697
[TBL] [Abstract][Full Text] [Related]
3. Mutant thyroid hormone receptor beta represses the expression and transcriptional activity of peroxisome proliferator-activated receptor gamma during thyroid carcinogenesis.
Ying H; Suzuki H; Zhao L; Willingham MC; Meltzer P; Cheng SY
Cancer Res; 2003 Sep; 63(17):5274-80. PubMed ID: 14500358
[TBL] [Abstract][Full Text] [Related]
4. The steroid receptor coactivator-3 is a tumor promoter in a mouse model of thyroid cancer.
Ying H; Willingham MC; Cheng SY
Oncogene; 2008 Jan; 27(6):823-30. PubMed ID: 17653082
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer.
Furuya F; Lu C; Willingham MC; Cheng SY
Carcinogenesis; 2007 Dec; 28(12):2451-8. PubMed ID: 17660507
[TBL] [Abstract][Full Text] [Related]
6. AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma.
Kim CS; Vasko VV; Kato Y; Kruhlak M; Saji M; Cheng SY; Ringel MD
Endocrinology; 2005 Oct; 146(10):4456-63. PubMed ID: 16002527
[TBL] [Abstract][Full Text] [Related]
7. Molecular cytogenetic characterization of primary cultures and established cell lines from non-medullary thyroid tumors.
Foukakis T; Thoppe SR; Lagercrantz S; Dwight T; Weng WH; Svensson A; Höög A; Zedenius J; Wallin G; Lui WO; Larsson C
Int J Oncol; 2005 Jan; 26(1):141-9. PubMed ID: 15586234
[TBL] [Abstract][Full Text] [Related]
8. Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis.
Suzuki H; Willingham MC; Cheng SY
Thyroid; 2002 Nov; 12(11):963-9. PubMed ID: 12490073
[TBL] [Abstract][Full Text] [Related]
9. The pituitary tumor-transforming gene promotes angiogenesis in a mouse model of follicular thyroid cancer.
Kim CS; Ying H; Willingham MC; Cheng SY
Carcinogenesis; 2007 May; 28(5):932-9. PubMed ID: 17127711
[TBL] [Abstract][Full Text] [Related]
10. Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma.
Lu C; Zhao L; Ying H; Willingham MC; Cheng SY
Endocrinology; 2010 Apr; 151(4):1929-39. PubMed ID: 20133453
[TBL] [Abstract][Full Text] [Related]
11. Thyroid hormone receptor beta mutations in the 'hot-spot region' are rare events in thyroid carcinomas.
Rocha AS; Marques R; Bento I; Soares R; Magalhães J; de Castro IV; Soares P
J Endocrinol; 2007 Jan; 192(1):83-6. PubMed ID: 17210745
[TBL] [Abstract][Full Text] [Related]
12. PPARgamma insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-kappaB signaling pathway.
Kato Y; Ying H; Zhao L; Furuya F; Araki O; Willingham MC; Cheng SY
Oncogene; 2006 May; 25(19):2736-47. PubMed ID: 16314832
[TBL] [Abstract][Full Text] [Related]
13. Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor.
Guigon CJ; Zhao L; Lu C; Willingham MC; Cheng SY
Mol Cell Biol; 2008 Jul; 28(14):4598-608. PubMed ID: 18474620
[TBL] [Abstract][Full Text] [Related]
14. Cardiac glucose utilization in mice with mutated alpha- and beta-thyroid hormone receptors.
Esaki T; Suzuki H; Cook M; Shimoji K; Cheng SY; Sokoloff L; Nunez J
Am J Physiol Endocrinol Metab; 2004 Dec; 287(6):E1149-53. PubMed ID: 15304375
[TBL] [Abstract][Full Text] [Related]
15. Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone beta receptor.
Furuya F; Hanover JA; Cheng SY
Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1780-5. PubMed ID: 16446424
[TBL] [Abstract][Full Text] [Related]
16. Follicular thyroid carcinoma: chromosome analysis of 19 cases.
Roque L; Clode A; Belge G; Pinto A; Bartnitzke S; Santos JR; Thode B; Bullerdiek J; Castedo S; Soares J
Genes Chromosomes Cancer; 1998 Mar; 21(3):250-5. PubMed ID: 9523201
[TBL] [Abstract][Full Text] [Related]
17. Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance.
Miller LD; McPhie P; Suzuki H; Kato Y; Liu ET; Cheng SY
Genome Biol; 2004; 5(5):R31. PubMed ID: 15128445
[TBL] [Abstract][Full Text] [Related]
18. Alterations in genomic profiles during tumor progression in a mouse model of follicular thyroid carcinoma.
Ying H; Suzuki H; Furumoto H; Walker R; Meltzer P; Willingham MC; Cheng SY
Carcinogenesis; 2003 Sep; 24(9):1467-79. PubMed ID: 12869418
[TBL] [Abstract][Full Text] [Related]
19. Isoform-dependent actions of thyroid hormone nuclear receptors: lessons from knockin mutant mice.
Cheng SY
Steroids; 2005; 70(5-7):450-4. PubMed ID: 15862829
[TBL] [Abstract][Full Text] [Related]
20. PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.
Guigon CJ; Zhao L; Willingham MC; Cheng SY
Oncogene; 2009 Jan; 28(4):509-17. PubMed ID: 18997818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
